Bimekizumab National Webinar series; ÂPsoriasis Redefined: The next innovation in skin has arrivedÂ: Webinar 3 Â Bimekizumab in Practice
08 Dec 2021
About the event
The National Webinar series will consist of three hybrid meetings; each comprising live-streamed presentations and interactive Q&A sessions with the audience. Webinar 3 will also include a choice of two workshop sessions. Our overall objective is to provide delegates with the clinical knowledge and confidence to use bimekizumab appropriately as a new biologic therapy in suitable patients with plaque. psoriasis. All webinars will be streamed live to registered delegates. On-demand recordings of the webinars will be made available on a dedicated section of the UCB Connect website for 1 year post-meeting.
We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients in need.